Revenio Group Oyj is a Finland‐based medical technology company specializing in ophthalmic diagnostic instruments. The company’s core business centers on the design, manufacture and sales of intraocular pressure (IOP) measurement devices that support glaucoma screening, diagnosis and long‐term patient monitoring. Utilizing patented rebound tonometry technology, Revenio’s tonometers provide rapid, non-invasive IOP readings without the need for topical anesthesia, making them well‐suited for both clinical and home settings.
Revenio’s product portfolio is anchored by the Icare® family of tonometers, which includes the Icare PRO for clinical use and the Icare HOME for patient self-monitoring. These handheld devices leverage a small, disposable probe to gently make contact with the cornea, transmitting precise pressure measurements to the user. In addition to tonometry, the company has continued to broaden its ophthalmic diagnostics line, exploring solutions that address ocular surface assessment and other emerging needs in eye care.
Founded in 1981 and headquartered in Vantaa, Finland, Revenio Group has built a global distribution network spanning Europe, North America, Asia-Pacific and Latin America. The company maintains subsidiaries and partnerships in key markets such as the United States, Germany, the United Kingdom and Japan. Revenio’s management team comprises professionals with expertise in medical technology, engineering and life sciences, guiding the company’s growth and innovation efforts in the competitive ophthalmology sector.
AI Generated. May Contain Errors.
